SCHEMBL13764461

SCHEMBL13764461

C/C=C/C(=O)c1c(OCC(C)=O)cc(OCc2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 1/20 0.45
SLC5A2 P31639 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
MAOB P27338 3/20 0.43
HDAC8 Q9BY41 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
BRD4 O60885 1/20 0.40
GSK3B P49841 2/20 0.40
BACE1 P56817 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13764468 0.86 SLC5A1 (0.56) SLC5A1SLC5A2MEN1KMT2APDE4A
SCHEMBL11739144 0.78 MAOB (0.59) MEN1KMT2AMAOBKDM4EALDH1A1
SCHEMBL13764460 0.75 MAOB (0.47) SLC5A1SLC5A2MEN1KMT2AMAOB
SCHEMBL2951462 0.74 MEN1 (0.65) MEN1KMT2AMAOB
SCHEMBL658101 0.74 MAOB (0.61) SLC5A1SLC5A2MEN1KMT2AMAOB
SCHEMBL30141054 0.74 MAOB (0.61) SLC5A1SLC5A2MEN1KMT2AMAOB
SCHEMBL10610437 0.74 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL10610432 0.74 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL1727983 0.73 SLC5A1 (0.72) SLC5A1SLC5A2MEN1KMT2APDE4A
SCHEMBL1727986 0.73 SLC5A1 (0.72) SLC5A1SLC5A2MEN1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566699-B2 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 US disclosed